Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Vertex dedicates significant efforts to MDR-reversing agents

May 3, 1996

Receptagen will develop vitamin B12 uptake inhibitors

May 3, 1996

Somatix receives patent protection for novel glioma treatment

May 3, 1996

NSAID blocks carcinogenesis in rodent models

May 3, 1996

Targretin clinical trials update

May 3, 1996

Eisai presents preliminary data on ER-34335

May 3, 1996

AG-3340 on track for clinical testing

May 3, 1996

Sankyo macrophage activators claimed as immunostimulants, antineoplastics

May 3, 1996

Milkhaus to initiate phase I testing of LDI-200 in solid tumors

May 3, 1996

Efficacy data for Gonadimmune reported at AACR

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...